Updated schedule for the period 22-25 April vaccination program against COVID-19
, 21-04-2021
COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
, 20-04-2021
The implementation of the National Vaccination Plan continues – Appointments available for individuals aged 51-52
, 18-04-2021
Press conference on the next steps of the vaccination plan
, 16-04-2021
200,000 vaccinations administered in Cyprus until today – Priority to 53-54 age group for vaccination appointments on 16-17 April
, 15-04-2021
Janssen vaccine will not be administered pending the completion of the investigation of thrombosis cases in the USA
, 14-04-2021
AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets
, 14-04-2021
No self-isolation required for close contacts who have been vaccinated
, 14-04-2021
General instructions to persons vaccinated - Janssen (Johnson&Johnson) Vaccine
, 14-04-2021
Requests for the COVID-19 home vaccination of bedridden individuals end on 16 April
, 13-04-2021
Vaccination appointment programme for the period 13-17 April
, 12-04-2021
Vaccination portal opens on Sunday for individuals belonging to specific vulnerable groups
, 10-04-2021
Access to the Vaccination Portal for the arrangement of appointments by individuals aged 59 and 60
, 09-04-2021
AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
, 07-04-2021
19,378 appointments to be made available for the vaccination of persons aged 61 and over
, 06-04-2021
Vaccination Portal opens for individuals who use biological agents or other immunosuppressive medicines
, 04-04-2021
AstraZeneca COVID-19 vaccine: review of very rare cases of unusual blood clots continues
, 31-03-2021
Vaccination Portal to be made available for people aged 64 and over, on 1 April
, 31-03-2021
Vaccination Portal available until 31 March for patients with Diabetes Mellitus and Severe Obesity
, 31-03-2021
Over 19,000 vaccination appointments for individuals with Diabetes Mellitus and Severe Obesity
, 28-03-2021
Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna
, 26-03-2021
COVID-19 Vaccine AstraZeneca – Update on ongoing evaluation of blood clot cases
, 26-03-2021
A total of 310,000 individuals will have received at least the 1st dose of a vaccine by the beginning of May
, 22-03-2021
Rescheduling of postponed appointments for vaccination with the AstraZeneca vaccine
, 21-03-2021
The Vaccination Portal will be made available for people aged 66 and over on 20 – 21 March
, 19-03-2021
AstraZeneca vaccinations to be carried out normally
, 18-03-2021
COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets
, 18-03-2021
Investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events continues
, 16-03-2021
Postponement of vaccinations with the AstraZeneca vaccine until 18 March
, 15-03-2021
EMA’s Safety Committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events – further update
, 15-03-2021
Answers to frequently asked questions on COVID-19 Vaccine Janssen
, 11-03-2021
EMA recommends COVID-19 Vaccine Janssen (Johnson&Johnson) for authorisation in the EU
, 11-03-2021
COVID-19 Vaccine AstraZeneca: PRAC preliminary view suggests no specific issue with batch used in Austria
, 11-03-2021
Vaccination Portal to be made available for people aged 67 and over – 22,808 vaccination appointments
, 08-03-2021
EMA starts rolling review of the Sputnik V COVID-19 vaccine
, 04-03-2021
Vaccination Portal to be made available for people aged 69 and over – 17,496 vaccination appointments
, 02-03-2021
The objectives of the National Vaccination Plan are being achieved – More than 64,000 vaccines have been administered by the 23rd February
, 24-02-2021
As of 23 February, 16,904 vaccination appointments will be made available for people aged 71 and over
, 22-02-2021
COVID-19 Vaccination of specific categories of the population based on serious illness risk factors
, 19-02-2021
National Vaccination Plan for COVID-19: 9.096 appointments for persons aged 74 and over
, 16-02-2021
Statement by the Minister of Health, Mr Constantinos Ioannou, at the press conference on the National Vaccination Plan for COVID-19
, 12-02-2021
EMA starts rolling review of CureVac’s COVID-19 vaccine (CVnCoV)
, 12-02-2021
9,264 Vaccination appointments made available for people over the age of 76
, 11-02-2021
Clarifications regarding the administration of AstraZeneca vaccine to specific age groups
, 10-02-2021
Third phase of the National Vaccination Plan for COVID-19 begins with appointments made available for people over the age of 79
, 09-02-2021
General instructions to persons vaccinated - AstraZeneca Vaccine
, 09-02-2021
EMA starts rolling review of Novavax’s COVID-19 vaccine (NVX-CoV2373)
, 04-02-2021
Vaccination Portal to be made available to citizens over the age of 83
, 02-02-2021
Vaccination appointments for citizens over the age of 84 – 7,790 vaccine doses administered during the week of 23-29 January
, 30-01-2021
EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in the EU
, 29-01-2021
Answer to frequently-asked questions on COVID-19 Vaccine AstraZeneca
, 29-01-2021
COVID-19 vaccine safety update for Comirnaty
, 29-01-2021
First COVID-19 vaccine safety update published
, 29-01-2021
Clarification of Comirnaty dosage interval
, 29-01-2021
Vaccination Portal to be made available to citizens over the age of 86 as of 29 January – New appointments as of 1st February
, 28-01-2021
Vaccination Portal to be made available to citizens over the age of 88 as of 27 January
, 26-01-2021
General instructions to persons vaccinated - Moderna Vaccine
, 13-01-2021
EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca
, 12-01-2021
EMA recommends COVID-19 Vaccine Moderna for authorisation in the EU
, 06-01-2021
Answers to frequently asked questions on COVID-19 Vaccine Moderna
, 06-01-2021
GHS Beneficiary Portal User Manual for COVID-19 Vaccination
, 04-01-2021
Application process for the registration to Covid-19 Vaccinations’ Portal of citizens who are not GHS beneficiaries
, 04-01-2021
Document for the Registration of Citizens who are not GHS beneficiaries, to the Cyprus Portal for COVID-19 vaccinations
, 04-01-2021
Update on rolling review of AstraZeneca’s COVID-19 vaccine
, 31-12-2020
General instructions to persons vaccinated - Comirnaty (Pfizer/BioNTeck) Vaccine
, 28-12-2020
First batch of Pfizer-BioNTech vaccines to be delivered on 26 December – vaccinations to begin on 27 December
, 22-12-2020
Answers to frequently asked questions about Comirnaty - COVID-19 mRNA vaccine (nucleoside modified)
, 22-12-2020
EMA recommends first COVID-19 vaccine for authorisation in the EU
, 21-12-2020
Update on assessment of the BioNTech and Pfizer BNT162b2 vaccine marketing authorisation application
, 16-12-2020
Answers to frequently asked questions about vaccines/vaccination against COVID-19
, 15-12-2020
The National Vaccination Plan for COVID-19 was presented
, 15-12-2020
National Vaccination Plan for Covid-19
, 15-12-2020